Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
By Senad KaraahmetovicBank of America strategist Anthony Cassamassino listed 10 high-conviction stocks for the third quarter that started today.The list consists of 9 long and 1...
Pfizer, Inc. (NYSE: PFE) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the full approval of Paxlovid, its antiviral pill for...
Pfizer Inc (NYSE: PFE) has submitted a new drug application to the FDA for the approval of Paxlovid for patients at high risk for progression to severe illness from...
Biden Admin Inks $3.2 Billion Deal With Pfizer For 105 Million COVID-19 VaccinesAuthored by Tom Ozimek via The Epoch Times (emphasis ours),The Biden administration said it has...
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled studies completed to date, oral brepocitinib generated...
Shares of Pfizer are down over 12.5% since the start of 2022.Plan to spend cash generated from COVID-19 vaccine on M&As and share buybacks.Long-term investors may consider...
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 32.50 | 32.64 | 31.89 | -0.22 | -0.67% | 114.26K | Toronto | |||
| 14.05 | 14.13 | 13.79 | +0.03 | +0.21% | 434.99K | Toronto | |||
| 53.23 | 53.35 | 51.17 | +0.53 | +1.01% | 68.03K | Toronto | |||
| 17.30 | 17.35 | 17.16 | -0.07 | -0.40% | 3.16M | Toronto | |||
| 0.39 | 0.39 | 0.39 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 60.30 | 60.49 | 60.00 | -0.30 | -0.50% | 1.52M | Toronto | |||
| 0.05 | 0.05 | 0.045 | 0.0000 | 0.00% | 0.00 | TSXV | |||
| 0.075 | 0.075 | 0.075 | 0.0000 | 0.00% | 0.00 | CSE | |||
| 0.39 | 0.38 | 0.38 | 0.00 | 0.00% | 1.20K | Toronto | |||
| 11.87 | 12.94 | 11.64 | -1.07 | -8.27% | 112.99K | Toronto | |||
| 0.30 | 0.33 | 0.30 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 0.105 | 0.11 | 0.105 | 0.000 | 0.00% | 0.00 | TSXV | |||
| 16.45 | 16.81 | 16.40 | -0.24 | -1.44% | 328.75K | Toronto | |||
| 84.37 | 84.79 | 82.38 | -0.18 | -0.21% | 736.16K | Toronto | |||
| 38.31 | 38.38 | 37.65 | +0.15 | +0.39% | 686.60K | Toronto |